CVR 71169413Private limited company (ApS)Engroshandel med læge- og hospitalsartikler (464620)Vassingerødvej 9, 3540 LyngeFounded 2 Jul 1982
Compare withsimilar companiesanother companyits industry
MIFAMED ApS
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: MIFAMED ApS, https://dandex.ai/company/71169413/mifamed. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about MIFAMED ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexEmployees
0
CVR, 2000
Result
-21.3K
DKK, annual report 2020
Equity
2.3M
DKK, annual report 2020
MISSIONPHARMA GROUP ApSCVR 29782792, 100% of capital and votes, until 30 Dec 2020
Poul Lindofuntil 30 Dec 2020
Christian Monrad Overgaarduntil 30 Dec 2020
No current owner is registered.
CVR 29782792100% of capital and votes30 Apr 2009 to 30 Dec 2020
CVR lists no current officers for this company.
2000, annual: 0 employees, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1997 | 1998 | 1999 | 2000 |
|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 0 |
| FTE | 1 | 1 | 1 | 1 |
| Series | Annual | Annual | Annual | Annual |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest 2000, published 24 May 2002.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2020, DKK: Operating profit -11.8K, Result for the year -21.3K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2020, DKK: Total assets 2.3M, Equity 2.3M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Operating profit | -12 | -6 | 0 | -13 | -12 |
| Result for the year | -19 | -1 | -3 | -20 | -21 |
| Equity | 2,356 | 2,355 | 2,352 | 2,331 | 2,310 |
| Total assets | 2,374 | 2,365 | 2,362 | 2,345 | 2,333 |
Not every period is a full year: 2018 covers 3 months (1 Jan to 31 Mar 2018). Changes against it compare periods of different length.
Annual report 2020
1 Apr 2019 to 31 Mar 2020, published 7 Jul 2020
Annual report 2019
1 Apr 2018 to 31 Mar 2019, published 10 Jul 2019
Annual report 2018
1 Jan 2018 to 31 Mar 2018, published 19 Jun 2018
Annual report 2017
Published 14 Jun 2018
Annual report 2016
Published 1 Jun 2017
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseBonus issue from reserves | None | None | None | 200,000 | |
| FoundingNot read from the announcement | None | None | None | 80,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Merger (fusion), as the ceasing company (ophørende selskab)
Source: CVR, read 22 Nov 2026.
27 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en fusionsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende selskaber må antages at være tilstrækkeligt sikrede efter fusionen.
Virksomheden er d. 30.12.2020 opløst ved fusion med CVR-nummer: 29782792 MISSIONPHARMA GROUP ApS.
Vedtægter ændret: 13.02.2019
Bestyrelse:
Fratrådte:
Kim Erik Ginnerup, den 13.02.2019.
Tiltrådte:
Kim Erik Ginnerup, (næstformand), den 13.02.2019, Annie Renée Simonne Dateu, den 13.02.2019, Aymeric Erouart, den 13.02.2019.
Selskabet tegnes af to bestyrelsesmedlemmer i forening, eller af to direktører i forening, eller af den samlede bestyrelse.
Direktion:
Fratrådte:
Kim Erik Ginnerup (adm. dir), den 30.08.2018.
Tiltrådte:
Christian Monrad Overgaard (adm. dir), den 30.08.2018.
Vedtægter ændret: 06.12.2017
Regnskabsår ændret til: 01.04 - 31.03
Omlægningsperiode: 01.01.2018 - 31.03.2018
CVR-nummer
71169413.
NAVN:
MIFAMED ApS.
Adresse: Vassingerødvej 9, 3540 Lynge.
Kommune: Allerød.
Revision:
Fratrådte:
KPMG STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 20.04.2015.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 20.04.2015.
Direktion:
Udtrådt af direktionen:
Mikkel Mørkedal Wakefield, den 15.03.2013.
Indtrådt i direktionen:
Direktør Kim Erik Ginnerup (adm. dir), den 15.03.2013.
Direktion:
Tiltrådt som Økonomidirektør:
Poul Lindof, den 30.11.2012.
Indtrådt i direktionen:
Mikkel Mørkedal Wakefield (adm. dir), den 30.11.2012.
Vedtægter ændret:
20.11.2012.
Ny adresse:
Vassingerødvej 9, 3540 Lynge.
Ny kommune:
Allerød.
Revision:
Udtrådt af revisionen:
CVR-NR. 26052394 ERNST & YOUNG P/S, den 20.11.2012.
Indtrådt i revisionen:
CVR-NR. 30700228 KPMG STATSAUTORISERET REVISIONSPARTNERSELSKAB, Osvald Helmuths Vej 4, postboks 250, 2000 Frederiksberg, den 20.11.2012.
Regnskabsår ændret til:
01.01 - 31.12.
Omlægningsperiode:
01.05.2012 - 31.12.2012.
Vedtægter ændret:
01.11.2012.
Bestyrelse:
Indtrådt i bestyrelsen:
Jean-Marc Pierre Rene Leccia (formand), den 01.11.2012, Denis Georges Fernand Maurice (næstformand), den 01.11.2012, Direktør Kim Erik Ginnerup, den 01.11.2012, Eric Pierre Jean Muris, den 01.11.2012.
Selskabets tegnes af to bestyrelsesmedlemmer i forening, af tre direktører i forening, af næstformanden for bestyrelsen i forening med en direktør eller af den sam-lede bestyrelse.
Vedtægter ændret:
27.09.2010.
Vedtægter ændret:
04.01.2010.
Ny adresse:
Langelinie Allé 7, 5., 2100 København Ø.
Ny kommune:
København.
Direktion:
Udtrådt af direktionen:
Christian Ilsøe, den 04.01.2010.
Indtrådt i direktionen:
Direktør Poul Lindof, den 04.01.2010.
Vedtægter ændret:
08.12.2008.
Ny adresse:
Hvedevangen 9, 3400 Hillerød.
Ny kommune:
Hillerød.
Direktion:
Udtrådt af direktionen:
Kim Erik Ginnerup, den 08.12.2008.
Indtrådt i direktionen:
Christian Ilsøe, den 08.12.2008.
Revision:
Udtrådt af revisionen:
Statsaut. revisor Niels Harder, den 30.11.2004.
Indtrådt i revisionen:
CVR-NR. 73317428 ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, Tagensvej 86, 2200 København N, den 30.11.2004.
Vedtægter ændret:
21.08.2003.
Ny adresse:
Vassingerødvej 9, 3540 Lynge.
Ny kommune:
Allerød.
Direktion:
Udtrådt af direktionen:
Martin Møller Olesen, den 21.08.2003.
Indtrådt i direktionen:
Direktør Kim Erik Ginnerup, den 21.08.2003.
Direktion:
Udtrådt af direktionen:
Jørgen Edvard Laursen, den 29.01.2003.
Indtrådt i direktionen:
Martin Møller Olesen, den 29.01.2003.
Vedtægter ændret:
18.11.1998.
Direktion:
Udtrådt af direktionen:
Kim Erik Ginnerup, den 18.11.1998, Paule Georgette Ginnerup, den 18.11.1998.
Indtrådt i direktionen:
Jørgen Edvard Laursen, den 18.11.1998.
Selskabet tegnes af en direktør.
Vedtægter ændret:
07.03.1997.
Ny adresse:
Jægersborg alle 58, 2920 Charl.
Ny kommune:
Gentofte.
Vedtægter ændret:
24.03.1995.
Nyt navn:
MIFAMED ApS.
Ny adresse:
La Cours Vej 16, 1., 2000 Frederiksberg.
Ny kommune:
Frederiksberg.
Nye binavne:
MIPHAMED ApS (MIFAMED ApS) MIFA MEDICAL ApS (MIFAMED ApS).
Slettet binavn: MIPHA MEDICAL ApS (MIPHAMED ApS).
Vedtægter ændret:
22.06.1994.
Vedtægter ændret:
29.06.1993.
Kapitalforhøjelse:
kr. 120.000,00 indbetalt ved overførte reserver / overskud, kurs 100,00
Opdeling i kapitalklasser er ophævet
Kapitalen udgør herefter kr. 200.000,00
Vedtægter ændret:
17.07.1992.
Nyt navn:
MIPHAMED ApS
Nyt binavn: MIPHA MEDICAL ApS (MIPHAMED ApS)
Direktion:
Indtrådt i direktionen:
Stiftelsesdato:
02.07.1982
Seneste vedtægtsdato:
25.02.1985
Kapital:
kr. 80.000,00
Kapitalen er opdelt i klasser:
A kr. 10.000,00, B kr. 70.000,00
Indbetalingsmåde:
kontant/i værdier kr. 80.000,00 til kurs 100,0
Direktion:
Poul Ginnerup, Jannik Kenneth Rosenkrans Jensen
Selskabet tegnes af to direktører i forening
Revision:
Statsaut. revisor Niels Harder, 2200 København N
Første regnskabsår:
00.00 - 00.00
Regnskabsår:
01.05 - 30.04
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for MIFAMED ApS:
Have Pro? Sign in.
P-number 100676016358, 9999 Ukendt
P-number 1003608236Vassingerødvej 9, 3540 Lynge